Testing to predict outcome after transurethral resection of the prostate.

Testing to predict outcome after transurethral resection of the prostate.
复制标题

测试预测经尿道前列腺切除术后的结果。

DOI:
10.1016/s0022-5347(01)64958-9
复制
发表时间:
1997
期刊:
The Journal of urology
影响因子:
--
通讯作者:
M. Phelan
M. Phelan
中科院分区:
--
文献类型:
--
作者:
R. Bruskewitz;D. Reda;J. Wasson;L. Barrett;M. Phelan

文献摘要

参考文献

被引文献

相似文献

PurposeWe评估的能力,常规的临床试验,以预测结果经尿道前列腺切除术后的prostate.Materials and MethodsA共556名男性随机到一个试验的手术与观察等待进行了评估术前症状访谈,生活质量评估,尿流率,尿分析,标准的化学面板,后排尿残余尿测定和膀胱镜检查。预测避免术后并发症,改善生活质量和泌尿生殖系统症状的能力进行了评估,在249名男性随机接受经尿道前列腺切除术。结果最高的症状评分的患者最有可能有症状改善和那些最困扰的症状是最有可能改善生活质量。测量生理参数的客观测试对预测这些结果没有临床意义。较低的阻塞性症状评分和较大的围手术期静脉输液与更大的机会并发症。ConclusionsSymptom analysis和生活质量评估是最有用的选择患者经尿道前列腺切除术。客观的诊断测试是有限的额外好处。
PurposeWe assessed the ability of routine clinical tests to predict outcome following transurethral resection of the prostate.Materials and MethodsA total of 556 men randomized into a trial of surgery versus watchful waiting was evaluated preoperatively with symptom interview, quality of life assessment, uroflowmetry, urinalysis, standard chemistry panel, post-void residual urine determination and cystoscopy. The ability to predict avoidance of postoperative complications, and improvement in quality of life and genitourinary symptoms was assessed in the 249 men randomized to undergo transurethral resection of the prostate.ResultsPatients with the highest symptom scores were most likely to have symptom improvement and those most bothered by the symptoms were most likely to have improvement in quality of life. No objective tests measuring physiological parameters made clinically significant contributions toward predicting these outcomes. Lower obstructive symptom scores and larger perioperative infusions of intravenous fluids were associated with a greater chance of complications.ConclusionsSymptom analysis and quality of life assessment are most useful in selecting patients for transurethral resection of the prostate. Objective diagnostic tests are of limited additional benefit.